FDA panel backs Pfizer's Xeljanz as bowel disease treatment Ruby Khatun Khatun9 March 2018 10:00 AM ISTPfizer Inc’s Xeljanz should be approved to treat patients with moderate to severe ulcerative colitis, a chronic bowel disease, a U.S. Food and Drug...
Roche names William Pao as research and development head Ruby Khatun Khatun9 March 2018 9:45 AM ISTZURICH: Swiss drugmaker Roche said it will put a cancer specialist at the helm of its Swiss-based research efforts in April after the scientist who...
FDA receives new reports of issues with Bayer’s birth control device Essure Ruby Khatun Khatun9 March 2018 9:30 AM ISTThe U.S. Food and Drug Administration (FDA) is investigating new reports of Bayer’s implanted birth control device Essure causing problems during...
Major Investor In Manipal Healthcare now looking for Exit: Report Ruby Khatun Khatun8 March 2018 2:07 PM ISTNew Delhi: In less than a year, Temasek, a Singapore based sovereign wealth fund is looking to exit Bengaluru based multi-specialty hospital chain...
Sanofi may seek US approval for Dengvaxia despite Philippines outrage Ruby Khatun Khatun8 March 2018 10:30 AM ISTPARIS: French pharmaceuticals group Sanofi says it will decide shortly whether to seek regulatory approval for dengue vaccine Dengvaxia in the United...
EU medicines agency suspends and recall Biogen, AbbVie MS drug Zinbryta Ruby Khatun Khatun8 March 2018 10:15 AM ISTEurope’s medicines regulator recommended the immediate suspension and recall of Biogen Inc and AbbVie Inc’s multiple sclerosis drug Zinbryta,...
DoP invokes Emergency Clause- Directs Manufacturer to maintain HEP C medicine production Ruby Khatun Khatun8 March 2018 9:57 AM ISTNew Delhi: Department of Pharmaceuticals said it has invoked powers under the Drugs Prices Control Order, 2013 to direct Fulfords India to maintain...
Novartis, US partner plan remote trials to boost participation Ruby Khatun Khatun8 March 2018 9:45 AM ISTZURICH: Novartis plans up to 10 clinical trials over three years using a U.S. partner’s mobile technology to help free patients from burdensome...
Merck, Eisai in deal to further develop, sell Eisai cancer drug Ruby Khatun Khatun8 March 2018 9:30 AM ISTNEW YORK: Merck & Co Inc and Japan’s Eisai Co Ltd announced a potential multibillion-dollar collaboration to develop and sell Eisai’s cancer drug...
Syringes and needles being sold at 214 to 1251 percent margin: NPPA Ruby Khatun Khatun7 March 2018 4:13 PM ISTNew Delhi: NPPA seems to be shifting its focus on syringes and needles, as these medical equipment are being sold at very high margins.The National...
FDA approves new HIV treatment for patients having limited treatment options Ruby Khatun Khatun7 March 2018 11:00 AM ISTThe U.S. Food and Drug Administration (FDA) approved Trogarzo (ibalizumab-uiyk), a new type of antiretroviral medication for adult patients living...
MedGenome raises funds from HDFC group Ruby Khatun Khatun7 March 2018 10:30 AM ISTBengaluru: Genetic diagnostics company, MedGenome Labs Ltd., announced an investment by HDFC Ltd., HDFC Life, and HDFC Asset Management to complete...
